MONTPELIER- Even as COVID-19 infections and hospitalizations continue to fall in Vermont, the state is evaluating the potential impact of BA2, a variant of the COVID-19 Omicron strain.  
“We continue to monitor any developments concerning the BA2 subvariant of Omicron, both abroad and here in Vermont, through genetic sequencing and waste water surveillance,” said Vermont Health Commissioner Dr. Mark Levine at Tuesday’s COVID-19 press briefing.  “Unfortunately, we cannot predict exactly how it will affect us yet.”